1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione

1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione Struktur
1024388-14-4
CAS-Nr.
1024388-14-4
Englisch Name:
1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione
Synonyma:
1,3-bis(3-chlorophenyl)-5-{[4-(dimethylamino)phenyl]methylidene}-1,3-diazinane-2,4,6-trione;1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione;2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-bis(3-chlorophenyl)-5-[[4-(dimethylamino)phenyl]methylene]-
CBNumber:
CB0771995
Summenformel:
C25H19Cl2N3O3
Molgewicht:
480.34
MOL-Datei:
Mol file

1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione Eigenschaften

Sicherheit

1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione Chemische Eigenschaften,Einsatz,Produktion Methoden

1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Biosynth Biological Technology (Suzhou) Co Ltd --
sales@biosynth.com China 6032 58
Key Organics Ltd. --
info@keyorganics.net United Kingdom 6741 50
ABCR GmbH & CO. KG --
info@abcr.de Germany 6799 75
Menai Organics Ltd. --
menaiorganics@compuserve.com United Kingdom 5013 30

  • 1,3-bis(3-chlorophenyl)-5-{[4-(dimethylamino)phenyl]methylidene}-1,3-diazinane-2,4,6-trione
  • 2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-bis(3-chlorophenyl)-5-[[4-(dimethylamino)phenyl]methylene]-
  • 1,3-Bis(3-chlorophenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione
  • 1024388-14-4
Copyright 2019 © ChemicalBook. All rights reserved